Apr
30
2024
Newron Announces Positive Top-line Results From Potentially Pivotal Phase II/III Study 008A With Evenamide in Schizophrenia Patients
Newron announces positive top-line results from potentially pivotal Phase II/III study 008A with evenamide in schizophrenia patients …